- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
MEDX
EBS
Week ended 09 Oct 2026
Weekly Investor Report
medmix AG · Industrials · Specialty Industrial Machinery
Latest close
9.77 CHF
-1.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 11.6% above the Trend Line and sits at 45.5% of its 52-week range. The latest completed week returned -1.2%, after a 12.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
51
out of 100
Latest Close
9.77 CHF
9 Oct 2026
1W Return
-1.2%
latest completed week
4W Return
12.4%
short-term follow-through
12W Return
17.3%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.59% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.2%
Latest completed week; four-week move 12.4%.
Indicator stack
22/90
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.59%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 11.6% above the Trend Line and sits at 45.5% of its 52-week range. The latest completed week returned -1.2%, after a 12.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
9 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3312-week average 0.16
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.33Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.4% over four weeks, 17.3% over 12 weeks, and 12.9% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.65Latest activity-pressure read.
Pressure change125.7%Four-week change in activity pressure.
Leadership1.14Latest relative-leadership reading.
RS change111.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-20.1%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
17 Apr
15 May
12 Jun
10 Jul
7 Aug
4 Sep
9 Oct
Weeks higher13 of 2613 weeks finished lower.
Best week+12.5%Week of 25 Sep.
Worst week-5.7%Week of 26 Jun.
Latest week-1.2%Week of 9 Oct.
Shape of recent returns
Strong gains3
Modest gains10
Flat weeks0
Modest losses9
Sharp losses4
Recent vol4.6%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Industrials
4-week rank3 / 58
Group average-0.1%
Trend breadth48.3%
Trend48.3%active weekly trend signals
MD62.1%positive activity pressure
RS43.1%positive relative leadership
Four-week leaders
IndustryCH Specialty Industrial Machinery
4-week rank3 / 25
Group average0.0%
Trend breadth40.0%
Trend40.0%active weekly trend signals
MD72.0%positive activity pressure
RS40.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis47/100Latest 12-week confirmation: trend 4/12, activity pressure 11/12, relative leadership 3/12.
Activity pressure 0.33; No reversal markers Next-Week ExpectancyNegative 43.59%Next-week expectancy is negative with a 43.59% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
medmix Secures Second Consecutive CDP "A" Rating for Supplier Engagement Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 9 Oct 2026 | 9.77 CHF | -1.2% | 8.75 CHF | 11.23 CHF | 1.65 | 1.14 | 274.3K | On |
| 2 Oct 2026 | 9.89 CHF | -2.5% | 8.72 CHF | 11.29 CHF | 1.47 | 3.38 | 269.7K | On |
| 25 Sep 2026 | 10.14 CHF | 12.5% | 8.69 CHF | 11.35 CHF | 1.24 | 3.90 | 528.5K | On |
| 18 Sep 2026 | 9.01 CHF | 3.7% | 8.67 CHF | 11.43 CHF | 0.96 | -6.63 | 887.0K | On |
| 11 Sep 2026 | 8.69 CHF | -3.1% | 8.75 CHF | 11.50 CHF | 0.73 | -10.25 | 222.1K | Off |
| 4 Sep 2026 | 8.97 CHF | 0.4% | 8.84 CHF | 11.59 CHF | 0.73 | -11.80 | 63.5K | Off |
| 28 Aug 2026 | 8.93 CHF | 2.5% | 8.93 CHF | 11.68 CHF | 0.74 | -12.74 | 47.1K | Off |
| 21 Aug 2026 | 8.71 CHF | -5.0% | 9.01 CHF | 11.77 CHF | 0.73 | -15.80 | 49.1K | Off |
| 14 Aug 2026 | 9.17 CHF | 0.2% | 9.12 CHF | 11.86 CHF | 0.64 | -11.59 | 53.5K | Off |
| 7 Aug 2026 | 9.15 CHF | 3.5% | 9.21 CHF | 11.95 CHF | 0.47 | -13.28 | 31.5K | Off |
| 31 Jul 2026 | 8.84 CHF | 7.9% | 9.28 CHF | 12.03 CHF | 0.19 | -15.72 | 200.9K | Off |
| 24 Jul 2026 | 8.19 CHF | -1.7% | 9.36 CHF | 12.11 CHF | -0.04 | -22.59 | 296.1K | Off |
| 17 Jul 2026 | 8.33 CHF | 2.7% | 9.45 CHF | 12.20 CHF | -0.16 | -22.26 | 218.6K | Off |
| 10 Jul 2026 | 8.11 CHF | -0.7% | 9.53 CHF | 12.29 CHF | -0.25 | -24.58 | 67.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.